An inexpensive antidepressant drug has been found to reduce the risk of hospitalization in high-risk adults recently diagnosed with COVID-19 by over 30 percent, according to a study published in The Lancet Global Health. The study, titled, “Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, […]

The post Inexpensive Antidepressant Found to Reduce COVID-19 Hospitalizations by Over 30 Percent: Study appeared first on NTD.

The study, titled, “Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial,” was published on Oct. 27.